335 related articles for article (PubMed ID: 26876740)
1. Learning impairment by minimal cortical injury in a mouse model of Alzheimer's disease.
Zou J; Wang M; Uchiumi O; Shui Y; Ishigaki Y; Liu X; Tajima N; Akai T; Iizuka H; Kato N
Brain Res; 2016 Apr; 1637():56-63. PubMed ID: 26876740
[TBL] [Abstract][Full Text] [Related]
2. Improvement of spatial learning by facilitating large-conductance calcium-activated potassium channel with transcranial magnetic stimulation in Alzheimer's disease model mice.
Wang F; Zhang Y; Wang L; Sun P; Luo X; Ishigaki Y; Sugai T; Yamamoto R; Kato N
Neuropharmacology; 2015 Oct; 97():210-9. PubMed ID: 26051398
[TBL] [Abstract][Full Text] [Related]
3. Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer's disease.
Wang L; Kang H; Li Y; Shui Y; Yamamoto R; Sugai T; Kato N
Neuropharmacology; 2015 May; 92():8-15. PubMed ID: 25577958
[TBL] [Abstract][Full Text] [Related]
4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
6. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
7. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
[TBL] [Abstract][Full Text] [Related]
8. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
9. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
10. Cognitive Improvement by Photic Stimulation in a Mouse Model of Alzheimer's Disease.
Zhang Y; Wang F; Luo X; Wang L; Sun P; Wang M; Jiang Y; Zou J; Uchiumi O; Yamamoto R; Sugai T; Yamamoto K; Kato N
Curr Alzheimer Res; 2015; 12(9):860-9. PubMed ID: 26159188
[TBL] [Abstract][Full Text] [Related]
11. Disruption of sphingomyelin synthase 2 gene alleviates cognitive impairment in a mouse model of Alzheimer's disease.
Uchiumi O; Zou J; Yamaki S; Hori Y; Ono M; Yamamoto R; Kato N
Brain Res; 2024 Jul; 1835():148934. PubMed ID: 38609029
[TBL] [Abstract][Full Text] [Related]
12. Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice.
Tajiri N; Kellogg SL; Shimizu T; Arendash GW; Borlongan CV
PLoS One; 2013; 8(11):e78851. PubMed ID: 24223856
[TBL] [Abstract][Full Text] [Related]
13. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
[TBL] [Abstract][Full Text] [Related]
14. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
15. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
Tapia-Rojas C; Inestrosa NC
J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
[TBL] [Abstract][Full Text] [Related]
17. Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with Homer1a.
Yamamoto K; Ueta Y; Wang L; Yamamoto R; Inoue N; Inokuchi K; Aiba A; Yonekura H; Kato N
J Neurosci; 2011 Aug; 31(31):11100-9. PubMed ID: 21813671
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
Fabbro S; Schaller K; Seeds NW
J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
